Walleye Trading
AIMT

Walleye Trading’s Aimmune Therapeutics AIMT Stock Holding History

Walleye Trading’s Portfolio AIMT Stock Details AIMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-32,300
Closed -$540K – 4911
2020
Q2 		$540K Sell
32,300
-8,000
-20% -$136K ﹤0.01% 2222
2020
Q1 		$581K Sell
40,300
-3,800
-9% -$97.1K ﹤0.01% 1755
2019
Q4 		$1.48M Buy
44,100
+28,100
+176% +$786K 0.01% 1464
2019
Q3 		$335K Sell
16,000
-17,500
-52% -$357K ﹤0.01% 2490
2019
Q2 		$697K Buy
+33,500
New +$690K 0.01% 1909

Other funds holding AIMT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Walleye Trading's AIMT Position: Q2 2020 in Review

Walleye Trading sold out of Aimmune Therapeutics (AIMT) in Q2 2020, closing a stake of 7,240 shares — an estimated $123K sold.

Walleye Trading first reported a position in AIMT in Q1 2020 and held it in 1 quarter. The position peaked at $104K in Q1 2020. 165 funds tracked by Wall St. Rank hold AIMT as of Q2 2020.

  • Walleye Trading reported no remaining Aimmune Therapeutics position as of Q2 2020 after selling out during the quarter.
  • Walleye Trading sold 7,240 Aimmune Therapeutics shares in Q2 2020, an estimated $123K.
  • Walleye Trading first reported a position in Aimmune Therapeutics in Q1 2020 and held it in 1 quarter.
  • Walleye Trading's Aimmune Therapeutics position peaked at $104K in Q1 2020.
  • 165 funds tracked by Wall St. Rank held Aimmune Therapeutics as of Q2 2020.

Based on Walleye Trading's 13F filing for Q2 2020, filed 14 Aug 2020.